INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 46 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,077,000 | +55.9% | 13,500,000 | +58.8% | 0.08% | +46.4% |
| Q4 2020 | $9,668,000 | +4.7% | 8,500,000 | 0.0% | 0.06% | -5.1% |
| Q3 2020 | $9,232,000 | +11.4% | 8,500,000 | 0.0% | 0.06% | 0.0% |
| Q2 2020 | $8,286,000 | -34.8% | 8,500,000 | -44.0% | 0.06% | -41.0% |
| Q1 2020 | $12,704,000 | -21.3% | 15,171,000 | -9.0% | 0.10% | +25.0% |
| Q4 2019 | $16,133,000 | -3.8% | 16,671,000 | -16.7% | 0.08% | -12.1% |
| Q3 2019 | $16,764,000 | -13.9% | 20,004,000 | 0.0% | 0.09% | -15.7% |
| Q2 2019 | $19,470,000 | -3.5% | 20,004,000 | 0.0% | 0.11% | -14.3% |
| Q1 2019 | $20,183,000 | +42.5% | 20,004,000 | +0.0% | 0.13% | +35.5% |
| Q4 2018 | $14,164,000 | -17.0% | 20,000,000 | 0.0% | 0.09% | -1.1% |
| Q3 2018 | $17,065,000 | -6.8% | 20,000,000 | 0.0% | 0.09% | -16.1% |
| Q2 2018 | $18,304,000 | +2.8% | 20,000,000 | 0.0% | 0.11% | -3.4% |
| Q1 2018 | $17,798,000 | – | 20,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sycale Advisors (NY) LLC | 8,065,000 | $9,173,000 | 6.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 61,000,000 | $69,219,000 | 1.37% |
| Sonora Investment Management, LLC | 6,645,000 | $7,519,000 | 0.62% |
| ZAZOVE ASSOCIATES LLC | 4,377,000 | $4,951,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 22,362,000 | $25,324,000 | 0.54% |
| SSI INVESTMENT MANAGEMENT LLC | 6,532,000 | $7,328,000 | 0.52% |
| Context Capital Management, LLC | 2,163,000 | $2,438,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 35,070,000 | $39,493,000 | 0.29% |
| Cheyne Capital Management (UK) LLP | 450,000 | $509,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 32,500,000 | $36,552,000 | 0.22% |